HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Omecamtiv mecarbil: a promising new drug in systolic heart failure.

AuthorsMatthijs F L Meijs, Folkert W Asselbergs, Pieter A Doevendans
JournalEuropean journal of heart failure (Eur J Heart Fail) Vol. 14 Issue 3 Pg. 232-3 (Mar 2012) ISSN: 1879-0844 [Electronic] England
PMID22210833 (Publication Type: Editorial)
Chemical References
  • omecamtiv mecarbil
  • Urea
  • Myosins
Topics
  • Heart Failure, Systolic (drug therapy)
  • Humans
  • Muscle Cells (drug effects)
  • Myosins (biosynthesis, drug effects)
  • Urea (analogs & derivatives, therapeutic use)
  • Ventricular Function, Left (drug effects)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: